Evaluation of a New Diagnostic Kit for the Enzymatic Determination of Creatinine by Lanser, A. et al.
Lanser, Blijenberg and Leynse: The enzymatic determination of creatinine 633
J. Clin. Chem. Clin. Biochem.
Vol. 17,1979, pp. 633-638
Evaluation of a New Diagnostic Kit for the Enzymatic Determination of Creatinine
By A. Lanser, A G. Blijenberg and A Leijnse
Department of Clinical Chemistry, University Hospital, and Department of Chemical Pathology, Erasmus University
Rotterdam
(Received January 16/May 21,1979)
Summary: We have evaluated a new diagnostic kit for the enzymatic determination of creatinine in serum, plasma
and urine. The method was found to be linear up to 1000 μπιοΐ/ΐ. Within-run precision had a coefficient of variation
of 3.1-5.6 % for normal to slightly elevated values and of 2.3-3.3 % for values of about 320 μπιοΐ/ΐ. Day-to-day
precision was found to be 7.8 and 5.7 % for values of 94 and 141 μπιοΐ/ΐ, respectively. Mean analytic recovery was
98 %. Bilirubin and hemoglobin did not interfere in concentrations up to 490 and 240 μιηοΐ/ΐ, respectively. The
influence of lipids was studied. Correlation studies were done with two other methods, the Technicon SMA 12/60
method and the Dutch standard manual method.
Evaluation eines neuen diagnostischen Reagenzbesteckes f r die enzymatische Bestimmung von Kreatinin
Zusammenfassung: Ein neues diagnostisches Reagenzbesteck f r die enzymatische Bestimmung von Kreatinin in
Serum, Plasma und Harn wurde gepr ft. Die Methode mi t linear bis 1000 μιηοΐ/ΐ. F r die Pr zision in der Serie
wurde f r normale bis leicht erh hte Werte ein Variationskoeffizient (VK) von 3,1-5,6 %, fur Werte um 320 μηιοΐ/ΐ
ein VK von 2,3—3,3 % errechnet. Die Pr zision von Tag zu Tag ergab einen VK von 7,8 % f r 94 μιηοΐ/ΐ und einen
VK von 5,7 % f r 141 /unol/L Die Wiederfindung betrug im Mittel 98 %. Bilirubin (bis 490 μπιοΐ/ΐ) und H moglobin
(bis 240 μιηοΐ/ΐ) st rten die Bestimmung nicht. Der Einflu von Lipiden wurde untersucht. Untersuchungen der
Korrelation mit der Technicon SMA 12/60-Methpde und der Niederl ndischen manuellen Standardmethode wurden
durchgef hrt.
introduction
Many methods have been published for the determination
of creatinine in serum or plasma and urine. Most of
these methods are based on the reaction of creatinine
with an alkaline picrate reagent, the Jaffe reaction (1).
Both endp int and kinetic methods have been described.
Uirfprtunately, neither of these methods is specific for
creatinine. Furthermore, the Jaffe reaction is disturbed
by many common drugs and metabolites (2,3). Since
enzymatic methods are known for their specificity,
some investigators have been working on an enzymatic
creatinine determination (4,5). The diagnostic kit
"Creatinine Enzymatic" from Bpehringer Mannheim
GmbH is based on the work of Wahlefeld et al. (4). In
this test method, creatinine is hydrolyzed by the enzyme
creatinine-amidohydrolase (EC 3.5.2.10). For e chmol
of creatinine hydrolyzed, one mol of NAD+ is formed,
according to the following reaction sequence:
Creatinine+ H2 Ο
Creatine + ATP
ADP + PEP
Creatinine-amidohydrolase Prftotine
EC 3.5.2.10
Creatine Kinase
 Creatine-P + ADP
EC 2.7.3.2
Pyruvate Kinase
EC 2.7.1.40
Pyruvate + NADH + H+L»ctate Dehydrogenase jr ,
EC1
'
1
·
1
·
27
ATp
NAD-
Since normal serum also contains substances that can
cause conversion of NADH to NAD* (e.g. pyruvate), a
serum blank is necessary.
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Here, we report our experience with the Boehringer test
kit, with regard to linearity, precision, recovery and inter-
ference of bilirubin, hemoglobin and lipids. Furthermore,
we checked if commercial sera could be used for qua-
lity control purposes. Finally, we compared this method
with two other methods, the Technicon SMA 12/60
method, which is in routine use in our laboratory, and
the manual Dutch standard method.
the manufacturers' instructions for measurement at 340 nm. We
halved all volumes mentioned in the instruction sheet. All
samples were analyzed in duplicate.
Materials and Methods
Equipment
All absorbance measurements were performed at 340 nm on a
Beckman model 25 spectrophotometer. The instrument is
checked regularly with respect to wavelength (holmium) and
absorbance (cobalt sulphate) according to Rand (6). For pipetting
we used Eppendorf pipets with Eppendorf disposable tips.
Creatinine
Creatinine was purchased from E. Merck AG (cat. no. 5208).
Bilirubin
Bilirubin p.a. was obtained from E. Merck AG (cat.no. 24519).
A stock solution of bilirubin (5000 μηιοΐ/ΐ) was prepared
according to Dybkaer & Hertz (7) and small volumes of this
solution were added to serum samples. Final bilirubin concen-
trations in the serum samples were checked on our DuPont
Automatic Clinical Analyzer (aca).
Hemoglobin
A red cell hemolysate was prepared according to van Assendelft
(8). Small volumes of this hemolysate were added to serum
samples. Final hemoglobin concentrations were checked with
the method of Crosby & Furth (9).
Technicon SMA 12/60 method
Creatinine determinations were performed according to the
normal SMA 12/60 procedure. The creatinine tubing system of
our SMA 12/60 has been slightly modified by IJpma et al. (10).
Manual methods
For serum and urine determinations we used the methods of the
Dutch Standardization Committee on Clinical Chemistry. The
serum procedure is highly comparable to the method of Knoll
& Wisser (11). All samples were analyzed in duplicate.
Enzymatic method
The enzymatic method (Boehringer Mannheim Test Combination
Creatinine Enzymatic, cat. no. 166413) was applied according to
Results
Six different human serum pools were used for precision
studies. Samples used for day-to-day precision studies
were kept at -20 °C until needed. The results for the
enzymatic method are given in table 1.
For comparison, samples 2 and 4 from table 1 gave
within-run coefficients of variation of 1.1 and 0.9 %,
respectively on our SMA 12/60 (n = 20). the manual
method had within-run coefficients of variation of 4.0
and 1.1 % for values of 86 and 538 μπιοΐ/ΐ respectively
(n=10).
Linearity
Linearity was checked with primary standards. The
enzymatic method was linear up to 1000 /nnol/1, as is
shown in figure 1.
Since linearity is limited by the available amount of
NAPH in the reaction mixture and since serum itself
contains substances that can convert NADH to NAD+,
the linearity limit in serum may not be that high. In the
instruction sheet an upper limit of 712 μιηοΐ/ΐ is men-
tioned. In all further experiments we performed, every
sample with a creatinine concentration exceeding that
limit was diluted with saline.
Recovery
To six different human sera with creatinine concen-
trations ranging from 66 to 224 μπιόΙ/1, small volumes
of an aqueous creatinine solution (10 mmol/1) were
added. Table 2 shows the results of these recovery ex-
periments. Mean analytic recovery was found to be
98%.
Tab. 1. Results of precision studies with the enzymatic method, obtained with six different serum pools of human origin.
Within-run precision
Sample no.
1
2
3
4
Average
(μηιοΐ/ΐ)
85
119
321
•322
S.D.
(Mmol/1)
2.7
6.7
7.5
10.6
C.V.
(%)
3.1
5.6
2.3
3.3
n
22
20
22
20
Day-to-day precision
Sample no.
5
6
Average
(Mmol/1)
94
140
S.D.
(Mmol/1)
7.3
7.9
C.V.
<%)
7.8 ·
5.7
•n
10
11
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Tab. 3. Effects of increasing concentrations of bilirubin and
/ h e m o g l o b i n on the measured creatinine concentration.
Serum A Serum B Serum C
CreatinineBilirubin CreatinineBUirubin CreatinineHemoglobin
(Mmol/l) (μπιο1/1) (μπιοΐ/ΐ) (μιηοΐ/l) (/imol/1) (μηιοΐ/ΐ)
321 ±
310
/ 325
/ 317
./ 324
/ 3 2 1329
321
321
Ι Ι Ι Ι ^ 320
200 400 600 ΘΟΟ 1000 321
Standard creotinine concentration (μπιοΐ/ΐ)
15* 18
81
122
175
226
275
297
361
406
462
494
88 ±5*
87
90
87
92
90
90
91
92
91
89
17
60
97
146
197
248
284
318
321
359
468
313 ±
319
316
319
325
312
309
313
310
283
273
245
15* 10
34
49
81
99
148
174
213
244
286
312
380
Fig. 1. Linearity of the enzymatic method. Curve constructed
with aqueous standards.
* Average ± 2 S.D. for the original serum.
Tab. 2. Results of recovery studies with the enzymatic method
Sample no.
1.
2.
3.
4.
5.
5.
5.
5.
6.
6.
Initial
value
(μιηοΙ/1)
66
68
108
224
54
54
54
54
94
94
Added crea-
tinine
Oimol/l)
91
91
91
91
91
180
268
353
180
268
Final
value
(μΐηοΙ/1)
156
152
197
312
150
227
325
392
269
367
Recovery
(%)
99
92
98
97
105
96
101
96
96
101
Tab. 4. Influence of anticoagulants in common concentrations
on the measured creatinine concentration.
Anticoagulant
no
Sodium fluoride
Sodium oxalate
Sodium oxalate
Heparin-lithium*
Potassium EDTA*
Sodium fluoride/
Potassium oxalate*
Sodium citrate
Concentration
__
lg/1
lg/1
2g/l
7.5 kU/1
3g/l
lg/1
3g/l
6.2 g/1
Creatinine
(Mmol/l)
313 ±15
320
295
235
317
315
193
314
* Commercial tubes
Interferences
Bilirubin and hemoglobin were added to different serum
pools (see materials and methods). The effects of in-
creasing concentrations of bilirubin and hemoglobin are
summarized in table 3.
The influence of lipemia was checked with 22 lipemic
sera. The degree of Upemia, judged qualitatively, ranged
from slightly to severely lipemic. In general/lipemic
samples can cause measuring problems because of the
turbidity of the serum-reagent mixture. 19 of the 22
lipemic sera, with triglyceride concentrations in the
range of 2.7 to 7.5 mmol/1 and cholesterol concentrations
up to 11 mmol/1, could be measured without problems.
The other three lipemic sera had triglyceride concen-
trations of 9.0, 32.6 and 36.0 mmol/1 and could not be
measured without predilution of the samples. Both last
mentioned sera had to be diluted 5 times. The 19
aforementioned sera are represented in figure 2.
To check the interference of anticoagulants, we added
different anticoagulants to a serum pool in concentrations
commonly used. The results are represented in table 4.
A commonly used preservative, sodium azide, in a con-
centration of 1 g/1, was shown to have no effect on the
measured creatinine concentration.
Split-sample comparisons
We compared the enzymatic method with two other
methods, the SMA 12/60 method and the Dutch stan-
dard manual method (see materials and methods).
Serum samples were analyzed in duplicate by the three
aforementioned methods, urine samples were analyzed
in duplicate by the three aforementioned methods,
urine samples were analyzed with the enzymatic and
manual method only.
Figures 2,3 and 4 show the results of these comparisons.
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Fig. 2. Split-sample comparison between the enzymatic method (y-axis) and the SMA 12/60 method (x-axis). Straight line represents
the regression line (equation: y = -12.227 + 0.962 x; r = 0.998 n = 75).
• non-lipemic sera
α lipemic sera (not included in calculation of regression line).
100 200 300' 400 500 600 700 800 900 1000
Creatinine (Manua l method) [/imol/l]
Fig. 3. Split-sample comparison between the enzymatic method (y-axi$) and the manual method (x-axis). Straight line represents the
regression line (equation: y = -0.906 + 0.895 x; r = 0.998 n = 73).
• human sera
α commercial control sera (not included in calculation of regression line).
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Tab. 5. Specifications of the control sera tested.
Name
10 20
Creatinine (Manual method) [mmo(/l]
Fig. 4. Split-sample comparison between enzymatic method (y-
axis) and manual method (x-axis) for urine samples.
Straight line represents the regression line (equation:
y = 0.024 + 0.906 x; r = 0.987 n = 30)
Linear regression least squares analysis gave the following
regression equations and correlation coefficients:
serum: y (enzymatic) = -12.227 + 0.962 χ (SMA 12/60)
r = 0.998 (75 samples).
serum: y (enzymatic) = -0.906 + 0,895 χ (manual)
r = 0.998 (73 samples).
urine: y (enzymatic) = 0.024 + 0.906 χ (manual)
r = 0.987 (30 samples).
Control sera
The instruction sheet states that occasionally a serum
sample can have a very high NADH consuming activity
due to substances in the serum itself (e.g. pyruvate), so
that the amount of NADH in the reaction mixture is not
adequate. In our experiment series, we noticed this effect
twice, once with a human serum arid once with a commer-
cial serum (a Technicon SMA 12/60 calibration serum).
In this last serum, the measured creatinine concentration
was virtually zero (calibration value: 430 μπιοΐ/ΐ). When
we monitored the absorbance of the serum blank during
the incubation time, we found an absorbance decrease,
which was equivalent to the total amount of NADH in
the reaction mixture, so all available NADH was con-
sumed by substances in the serum itself. To check if
pyruvate was responsible for this effect, we determined
the pyruvate concentration in the Technicon serum with
a Boehringer test kit (Test Combination Pyruvate, cat. no.
124982). The concentration we found was 92 /imol/1,
which is higher than the normal range given in the in-
struction sheet (41-67 μιηοΐ/ΐ). However, this amount
cannot possibly cause the absorbance decrease we ob-
served. In order to investigate whether this effect also
applied to other commercial control and calibration sera,
Lot no. Manufacturer
Versatol
Versatol A
Versatol Pediatric
Versatol Calibrate level 1
Versatol Calibrate level 3
Versatol Calibrate level 3
Precinorm S
Precipath S
Wellcomtrol 2
Wellcomtrol 3
RIVA
RIVB
Labtrol E
Labtrol E
Monitrol IIE
Autonorm
0164024 General Diagnostics
2262043 General Diagnostics
4 B 392 General Diagnostics
1438045 General Diagnostics
1438045 General Diagnostics
1438045 General Diagnostics
813 Boehringer Mannheim
705 Boehringer Mannheim
K 4364 Wellcome
K 4175 Wellcome
70510 National Institute of Public
Health
61123 National Institute of Public
Health
LT-52 Dade
LT-56H Dade
PTD-51 A Dade
210 Nyegaard
we checked 16 different commercial sera from several
manufacturers, with the enzymatic and the manual
method. We did not notice the effect in any of these
sera. Table 5 specifies the commercial sera we used. The
concentration values we measured with both methods
are represented in figure 3.
Discussion
In this report, we have evaluated a new diagnostic kit
for the enzymatic determination of creatinine. The
method was found to be linear up to 1000 μπιοΐ/ΐ, tested
with aqueous standards. As we already mentioned, the
upper limit may not be that high in serum, due to the
NADH consumption by substances in the serum itself.
Mean analytic recovery was 98 %, which agrees well with
the results ofSzasz &Borner (5) and Wahlefeld et al.
(4). The results of our precision studies also agree with
those of the aforementioned authors. Both the enzy-
matic method and the manual method had comparable
precisions, whereas the SMA 12/60 showed a slightly
better precision. The coefficients of variation we found
compare favourably with the value which is presented as
a goal for analytical performance by the College of
American Pathologists in the work of Gilbert (12), i.e.
a coefficient of variation of 6.7 % at 132 μτηοΐ/ΐ.
Bilirubin did not interfere with the reaction, even in
very high concentrations (up to 490 μιηοΐ/ΐ). Hemoglobin
in concentrations above 240 μιηοΐ/ΐ lowered the meas-
ured creatinine values. Possibly other components from
the red cells are responsible for this effect too. Serum
hemoglobin concentrations above 240 μτηοΐ/ΐ are rare,
but may sometimes be found in pediatric samples (13).
With the exception of potassium oxalate, which seems to
inhibit the reaction, all anticoagulants we tested did not
interfere with the test method. Furthermore, according
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to the Test Report from Boehringer Mannheim (14),
the method is not disturbed by a number of common
drugs.
Lipemic samples, which are represented in figure 2, do
not appear to behave differently from non-lipemic sera.
If possible, we feel that dilution should be avoided be-
cause ol the possibility that the diluted serum sample
will have a very low creatinine concentration, which
cannot be measured with great precision.
Commonly available control sera can be used for quality
control purposes, although we feel that care should be
taken because of our experience with the Technicon
serum.
Correlation of the enzymatic method with both of the
other methods was good. Our enzymatic values were con-
sistently lower than the values we obtained with either
the manual or the SMA 12/60 method, but we did not
find a 20-25 % difference, as is reported by Szasz &
Börner (5). We have not yet studied the possible causes of
these differences.
Another important aspect of the test kit is its price. The
reagent price for one single enzymatic test is very high,
when compared to the reagent price for one single
manual or SMA 12/60 test, which is virtually negligible.
However, with the manual method not more than 30-
40 tests could be performed within 3 hours, whereas
with the enzymatic test 60 tests could be performed in
1.8 hours. When a price for one test (i.e. reagent cost +
personnel cost) is calculated on the basis of these facts,
both the manual and the enzymatic method are equally
expensive. Both methods are of course more expensive
than the SMA 12/60 method (about 4 times).
Summarizing, we feel that the enzymatic method is a
very valuable method, which is very specific for creatinine,
and virtually insensitive to the interfering factors we
tested. In its present form, the method is not readily
adaptable to fully automated systems, but no doubt
automated versions will be developed.
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